A physician can help determine what problem is actually being treated
Cycle length typically runs 12 to 16 weeks, followed by a 4-week break
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Lim JC, Grey AC, Zahraei A, Donaldson PJ
GLP1 medications produce the kind of significant, sustained weight loss (15 to 25 percent of body weight in clinical trials) that was previously achievable only through bariatric surgery
Disclaimer: GHK-Cu (50mg) is supplied strictly for laboratory research use only